January 26, 2015
Introduction: The UroLift® System treatment for BPH entered the US urologist’s armamentarium in September 2013 upon FDA clearance. With the issuance of Category 1 CPT coding January 1, 2015, we … Continued
January 22, 2015
The PANOVA trial will now be expanded to treat an additional twenty advanced pancreatic cancer patients with concomitant TTFields, gemcitabine and nab-paclitaxel January 12, 2015 10:19 AM Eastern Standard Time … Continued
January 21, 2015
NeoTract, Inc. Announces Publication Showing Sustained Safety and Efficacy Benefits for the Minimally Invasive UroLift System Treatment for Enlarged Prostate Significant Symptom Relief, Improved Urinary Flow Rates, and Preserved Sexual … Continued